We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+0.57%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$17.3B
AUM Growth
+$91.5M
Cap. Flow
+$336M
Cap. Flow %
1.94%
Top 10 Hldgs %
59.81%
Holding
1,066
New
76
Increased
460
Reduced
487
Closed
41

Top Buys

Rank Stock Value
1
HESM icon
Hess Midstream
HESM
+$99M
2
PAA icon
Plains All American Pipeline
PAA
+$94.7M
3
EPD icon
Enterprise Products Partners
EPD
+$41.7M
4
WES icon
Western Midstream Partners
WES
+$32.4M
5
IVV icon
iShares Core S&P 500 ETF
IVV
+$26M

Top Sells

Rank Stock Value
1
FNDX icon
Schwab Fundamental US Large Company Index ETF
FNDX
+$32.7M
2
ET icon
Energy Transfer Partners
ET
+$18.7M
3
FNDA icon
Schwab Fundamental US Small Company Index ETF
FNDA
+$17M
4
CCJ icon
Cameco
CCJ
+$14.7M
5
CQP icon
Cheniere Energy
CQP
+$13.1M

Sector Composition

Rank Sector Weight
1 Energy 68.28%
2 Technology 4.29%
3 Financials 3.4%
4 Consumer Discretionary 2.95%
5 Materials 2.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACRS icon
1026
Aclaris Therapeutics
ACRS
$730M
– –
-78,782
Closed -$121K
ALDX icon
1027
Aldeyra Therapeutics
ALDX
$91.7M
– –
-43,803
Closed -$252K
ALEC icon
1028
Alector
ALEC
$164M
– –
-74,933
Closed -$92.2K
AMLX icon
1029
Amylyx Pharmaceuticals
AMLX
$2.05B
– –
-67,597
Closed -$239K
ATLX icon
1030
Atlas Lithium Corp
ATLX
$82.3M
– –
-10,779
Closed -$55.7K
AURA icon
1031
Aura Biosciences
AURA
$729M
– –
-37,156
Closed -$218K
CIB icon
1032
Grupo Cibest SA
CIB
$20.4B
– –
-11,894
Closed -$478K
CRGX
1033
DELISTED
CARGO Therapeutics
CRGX
– –
-33,158
Closed -$135K
DAR icon
1034
Darling Ingredients
DAR
$9.93B
– –
-136,520
Closed -$4.26M
DEA
1035
Easterly Government Properties
DEA
$1.18B
– –
-10,184
Closed -$270K
ELDN icon
1036
Eledon Pharmaceuticals
ELDN
$276M
– –
-44,436
Closed -$151K
ENTA icon
1037
Enanta Pharmaceuticals
ENTA
$372M
– –
-16,257
Closed -$89.7K
FDMT icon
1038
4D Molecular Therapeutics
FDMT
$526M
– –
-32,811
Closed -$106K
FNDA icon
1039
Schwab Fundamental US Small Company Index ETF
FNDA
$9.17B
– –
-619,058
Closed -$17M
FNDX icon
1040
Schwab Fundamental US Large Company Index ETF
FNDX
$26.4B
– –
-1,385,646
Closed -$32.7M
IRWD icon
1041
Ironwood Pharmaceuticals
IRWD
$611M
– –
-116,860
Closed -$172K
JWN
1042
DELISTED
Nordstrom
JWN
– –
-28,250
Closed -$691K
LQDA icon
1043
Liquidia Corp
LQDA
$7.67B
– –
-62,656
Closed -$924K
LRMR icon
1044
Larimar Therapeutics
LRMR
$416M
– –
-47,460
Closed -$102K
MAG
1045
DELISTED
MAG Silver
MAG
– –
-392,675
Closed -$6M
MGNX icon
1046
MacroGenics
MGNX
$235M
– –
-48,646
Closed -$61.8K
MLYS icon
1047
Mineralys Therapeutics
MLYS
$2.35B
– –
-34,664
Closed -$550K
NAK
1048
Northern Dynasty Minerals
NAK
$885M
– –
-1,308,007
Closed -$1.5M
NMRA icon
1049
Neumora Therapeutics
NMRA
$276M
– –
-114,371
Closed -$114K
NTLA icon
1050
Intellia Therapeutics
NTLA
$1.5B
– –
-77,328
Closed -$550K
39 40 41
42
43

Similar funds

PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $20.7B AUM 292.88% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

ALPS Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, ALPS Advisors held 1,066 positions worth $17.3B, up 0.53% from $17.2B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

ALPS Advisors's Q2 2025 filing shows 76 new, 460 increased, 487 reduced and 41 closed positions. Its largest new stake was ALPS Dynamic US Dividend Advantage ETF: 231,612 shares worth $13.4M. The largest sale was Schwab Fundamental US Large Company Index ETF, an estimated $32.7M.

By sector, the portfolio is most concentrated in Energy at 68% of assets, down from 70% a quarter earlier, followed by Technology and Financials.

  • ALPS Advisors's largest Q2 2025 buy was ALPS Dynamic US Dividend Advantage ETF: 231,612 shares worth $13.4M.
  • ALPS Advisors added most to Hess Midstream in Q2 2025, an estimated $99M increase.
  • ALPS Advisors's biggest Q2 2025 reduction was Energy Transfer Partners, cutting an estimated $18.7M.
  • ALPS Advisors fully exited Schwab Fundamental US Large Company Index ETF in Q2 2025, selling an estimated $32.7M.
  • ALPS Advisors's ten largest holdings make up 60% of its $17.3B portfolio in Q2 2025.
  • ALPS Advisors opened 76 new positions and closed 41 in Q2 2025.
  • ALPS Advisors's portfolio value rose 0.53% quarter-over-quarter to $17.3B.

Based on ALPS Advisors's 13F filing for Q2 2025, filed 11 Aug 2025.